|
English
|
正體中文
|
简体中文
|
總筆數 :2854037
|
|
造訪人次 :
45367612
線上人數 :
854
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
顯示項目 2262556-2262565 / 2346973 (共234698頁)
<< < 226251 226252 226253 226254 226255 226256 226257 226258 226259 226260 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2022-03-04T03:48:07Z |
The Deubiquitinating Enzyme Inhibitor PR-619 Enhances the Cytotoxicity of Cisplatin via the Suppression of Anti-Apoptotic Bcl-2 Protein: In Vitro and In Vivo Study
|
Kuo K.-L.; Liu S.-H.; WEI-CHOU LIN; Chow P.-M.; Chang Y.-W.; Yang S.-P.; Shi C.-S.; Hsu C.-H.; Liao S.-M.; Chang H.-C.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:08Z |
High concentration of C5a-induced mitochondria-dependent apoptosis in murine kidney endothelial cells
|
Tsai I.-J.; WEI-CHOU LIN; Yang Y.-H.; Tseng Y.-L.; Lin Y.-H.; Chou C.-H.; Tsau Y.-K. |
| 臺大學術典藏 |
2022-03-04T03:48:08Z |
Trifluoperazine, an antipsychotic drug, effectively reduces drug resistance in cisplatin-resistant urothelial carcinoma cells via suppressing bcl-xl: An in vitro and in vivo study
|
Kuo K.-L.; Liu S.-H.; WEI-CHOU LIN; Hsu F.-S.; Chow P.-M.; Chang Y.-W.; Yang S.-P.; Shi C.-S.; Hsu C.-H.; Liao S.-M.; Chang H.-C.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:09Z |
The relationship of anti-phospholipase A2 receptor antibody and C5a complement with disease activity and short-term outcome in idiopathic membranous nephropathy
|
Chi J.N.; Lai T.S.; Wu C.F.; Fu T.Y.; Chou Y.H.; Chiu Y.L.; WEI-CHOU LIN; Chiang W.C.; Chen Y.M.; Wu M.S. |
| 臺大學術典藏 |
2022-03-04T03:48:11Z |
Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7)
|
WEI-CHOU LIN; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:11Z |
Histone deacetylase inhibitor, trichostatin a, synergistically enhances paclitaxel-induced cytotoxicity in urothelial carcinoma cells by suppressing the ERK pathway
|
Hsu F.-S.; Wu J.-T.; Lin J.-Y.; Yang S.-P.; Kuo K.-L.; WEI-CHOU LIN; Shi C.-S.; Chow P.-M.; Liao S.-M.; Pan C.-I.; Hong J.-Y.; Chang H.-C.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:12Z |
The presentation of proteinuria in an adolescent with new-onset diabetes after heart transplantation
|
Ho C.Y.; Chuang G.-T.; WEI-CHOU LIN; Tsai I.-J. |
| 臺大學術典藏 |
2022-03-04T03:48:12Z |
Clinical outcomes in patients with biopsy-proved diabetic nephropathy compared to isolated lupus or crescentic glomerulonephritis
|
Chou Y.-H.; WEI-CHOU LIN; Chen Y.-M. |
| 臺大學術典藏 |
2022-03-04T03:48:12Z |
MLN4924, a protein neddylation inhibitor, suppresses the growth of human chondrosarcoma through inhibiting cell proliferation and inducing endoplasmic reticulum stress-related apoptosis
|
Wu M.-H.; Lee C.-Y.; Huang T.-J.; Huang K.-Y.; Tang C.-H.; Liu S.-H.; Kuo K.-L.; Kuan F.-C.; WEI-CHOU LIN; Shi C.-S. |
| 臺大學術典藏 |
2022-03-04T03:48:13Z |
Direct visualization of microcirculation impairment after acute subdural hemorrhage in a novel animal model
|
Wang H.-C.; Tsai J.-C.; Lee J.-E.; Huang S.-J.; Po-Hao Huang A.; WEI-CHOU LIN; Hsieh S.-T.; Wang K.-C. |
顯示項目 2262556-2262565 / 2346973 (共234698頁)
<< < 226251 226252 226253 226254 226255 226256 226257 226258 226259 226260 > >>
每頁顯示[10|25|50]項目
|
